Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma

NCT00354926 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
67
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Applied Molecular Evolution